Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)

Clinical trial NCT01765283 · COMPLETED

Trial details

NCT number: NCT01765283
Sponsor: Cellaion SA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urea Cycle Disorders Crigler Najjar Syndrome

Start date: 2012-03-01
Primary completion: 2014-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.